MGXMetagenomi Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 18538
Ticker: MGX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2024-02-09
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: MGX

Detail

Enriched 2026-08-14 20:47

Market cap: $46,088,068.1
Shares outstanding (class): 37,646,858
Shares outstanding (weighted): 37,777,105
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 113
Location: EMERYVILLE, CA
Homepage: https://metagenomi.co
Description: Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance its signature gene editing systems. MGX-001 is its, wholly-owned development program in hemophilia A, where the company have demonstrated targeted genome editing and durable gene expression from a one-time treatment in non-human primates (NHPs) and an overall profile potentially competitive with best-in-class treatment options. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A from a single administration.

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $2.05M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$993.5K	0.00%	741,407 NS	FIGI
Ultra-Small Company Fund Bridgeway Funds, Inc.	—	$438.3K	0.51%	327,100 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$424.2K	0.00%	316,537 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$94.0K	0.01%	70,127 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$83.3K	0.07%	62,200 NS	FIGI
Spectrum Fund Meeder Funds	—	$7.4K	0.00%	5,496 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$7.0K	0.00%	5,198 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$3.4K	0.00%	2,500 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERMGX
FIGI_COMPOSITEBBG00Y5ZXS77
FIGI_SHARE_CLASSBBG00Y5ZXS95
CIK0001785279
ISINUS59102M1045
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Metagenomi is a biotech company developing gene editing therapies, fitting the BIOTECHNOLOGY industry under HEALTHCARE.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.